Chinook Therapeutics, Inc. (KDNY) Social Stream



Chinook Therapeutics, Inc. (KDNY): $40.39

0.09 (+0.22%)

POWR Rating

Component Grades

Momentum

B

Stability

F

Sentiment

Quality

C

Add KDNY to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#271 of 383

in industry

Featured Post From StockTwits About KDNY

$KDNY New SEC Filing: 8-K Earnings - CHINOOK THERAPEUTICS, INC. (0001435049) August 12


Item 2.02. Results of Operations and Financial Condition. On August 12, 2021, Chinook Therapeutics, Inc. ("Chinook") announced certain financial results for the second quarter ended June 30, 2021. A copy of Chinook's press release, titled "Chinook Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results" is furnished pursuant to Item 2.02 as Exhibit 99.1 hereto. Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Description 99.1 Press Release, dated August 12, 2021, titled "Chinook Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results" 104 Cover Page Interactive File (the cover page tags are embedded within the (...)

https://mkn.re/96333
MarketNewswire, published August 12, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!